Stevanato Group SpA (STVN) 뉴스

Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing

Stevanato Group recognized for excellence and leadership in implementing equipment and technology to respond...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group to Present at the Jefferies London Healthcare Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group Reports Third Quarter 2023 Financial Results

- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group Announces Voting Results from its Extraordinary General Meeting

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group to Livestream Inaugural Capital Markets Day on September 27, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form S-8 - Securities to be offered to employees in employee benefit plans